THE USE OF TNF-ALPHA ANTAGONIST AS DRUGS FOR THE TREATMENT OF PATIENTS WITH SEPSIS AND WITHOUT SUFFERING FROM TOTAL ORGAN FAILURE
The present invention relates to the use of Tumor Necrosis Factor (TNF) antagonists in the treatment of patients with an inflammatory reaction and without suffering from total organ failure.